Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial.
Blonde L, Bailey TS, Chao J, Dex TA, Frias JP, Meneghini LF, Roberts M, Aroda VR. Blonde L, et al. Among authors: meneghini lf. Adv Ther. 2019 Sep;36(9):2310-2326. doi: 10.1007/s12325-019-01033-1. Epub 2019 Jul 29. Adv Ther. 2019. PMID: 31359368 Free PMC article.
Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.
Oster G, Sullivan SD, Dalal MR, Kazemi MR, Rojeski M, Wysham CH, Sung J, Johnstone B, Cali AM, Wei LJ, Traylor L, Anhalt H, Hull M, Van Vleet J, Meneghini LF. Oster G, et al. Among authors: meneghini lf. Postgrad Med. 2016 Nov;128(8):731-739. doi: 10.1080/00325481.2016.1241663. Epub 2016 Oct 24. Postgrad Med. 2016. PMID: 27690710 Clinical Trial.
Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
Tong L, Pan C, Wang H, Bertolini M, Lew E, Meneghini LF. Tong L, et al. Among authors: meneghini lf. Diabetes Obes Metab. 2018 Apr;20(4):831-839. doi: 10.1111/dom.13156. Epub 2017 Dec 4. Diabetes Obes Metab. 2018. PMID: 29119712 Free PMC article.
Insulin therapy for type 2 diabetes.
Meneghini LF. Meneghini LF. Endocrine. 2013 Jun;43(3):529-34. doi: 10.1007/s12020-012-9817-6. Epub 2012 Oct 27. Endocrine. 2013. PMID: 23104148 Review.
Role of Devices in Insulin Delivery.
Meneghini LF, McNulty JN. Meneghini LF, et al. Diabetes Technol Ther. 2017 Feb;19(2):76-78. doi: 10.1089/dia.2017.0011. Diabetes Technol Ther. 2017. PMID: 28118052 No abstract available.
48 results